跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要以实际入组人群的标准化治疗效应为目标,并处理外部历史对照的基线不平衡。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Keisuke Hanada
Masahiro Kojima

单臂试验总体标准化历史对照设计的协变量自适应样本量重估

研究问题
当实际入组人群与历史对照或计划人群的基线分布不同,如何在不查看治疗组结局的情况下调整样本量并维持目标功效?
方法与思路
作者以实际入组人群定义标准化效应,通过预设平衡评分标准化历史对照,并依据累积基线协变量和停止规则更新样本量。
材料陈述的贡献
摘要给出条件与无条件功效解释及近似错误率控制的充分条件,并称分布偏移模拟中自适应设计比固定设计更接近目标功效。
阅读关注点
应核对历史对照可比性、平衡评分与标准化条件、随入组变化的估计目标,以及重复样本量重估和停止规则下的错误率论证。
阅读边界
这是 arXiv 预印本,同行评审与接收未经核实;摘要未给出充分条件细节或功效数值,结局盲态不能自动消除历史对照混杂。

原文摘要

Externally controlled single-arm trials are increasingly considered when randomized controls are infeasible, but baseline imbalance between the active-arm trial and historical controls complicates both estimation and sample size planning. We propose a population-standardized design framework in which the target estimand is defined for the actually enrolled active-arm population and historical-control outcomes are standardized to that population through a pre-specified balancing score. Building on this estimand, we develop an outcome-blinded, covariate-adaptive sample size re-estimation (SSR) procedure that updates the required sample size using only accumulating baseline covariates, without using active-arm outcomes during enrollment. The method combines an initial scenario-based design with sequential updates of the enrolled-population score distribution, standardized control parameters, and target sample size under pre-specified stopping rules. We give conditional and unconditional power interpretations and sufficient conditions for approximate type I error control under repeated blinded SSR. In simulation studies with distributional shifts between planned and true active-arm populations, fixed designs based only on planning assumptions lost power, whereas the proposed SSR maintained power near the target level and performed similarly to an oracle design. In an illustrative ADCS-based example, the proposed procedures yielded different final sample sizes across adjustment sets, reflecting evolving enrolled-population covariate profiles. These results support covariate-adaptive, outcome-blinded SSR as a practical design strategy for externally controlled single-arm trials that target population-standardized treatment effects.

笔记与分组